Informational only — Not medical advice. Always consult a licensed healthcare provider.

Community data Updated 2 months ago

Indications

Snofas nasal spray is used to treat the symptoms of seasonal and perennial allergic rhinitis in patients aged 2 years and older. Snofas inhalation powder is used as a once-daily maintenance treatment for asthma, taken as preventive therapy in patients aged 5 years and older. It is not intended for the relief of acute bronchospasm.

⚠️ Always consult a registered physician before taking any medicine.

Pharmacology

Fluticasone Furoate is a synthetic, trifluorinated corticosteroid with strong anti-inflammatory activity. Like other corticosteroids, it acts on a broad range of cell types (such as mast cells, eosinophils, neutrophils, macrophages, and lymphocytes) and inflammatory mediators (such as histamine, eicosanoids, leukotrienes, and cytokines).

Pregnancy & Breastfeeding

Use in pregnancy: This falls under Pregnancy Category C. There are no adequate, well-controlled studies of Fluticasone Furoate use in pregnant women, so it should only be used during pregnancy if the potential benefit to the mother outweighs the potential risk to the fetus.

Use in breastfeeding: It is not known whether Fluticasone Furoate passes into human breast milk. Because other corticosteroids have been found in breast milk, caution is advised when giving Fluticasone Furoate to a breastfeeding woman.

⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.

Dosage Reference

⚠️ Reference ranges from official sources only. Consult your doctor for personalized dosing.

Adults: Fluticasone Furoate Nasal Spray: Adults and children over 12 years should use 2 sprays in each nostril once a day. In some cases, 2 sprays into each nostril twice daily may be used, not exceeding 4 sprays. Children under 12 years (2 to 11 years) should use 1 spray in each nostril once a day. Patients should use Fluticasone Furoate nasal spray at regular intervals as directed, since its effectiveness depends on regular use. Children under 2 years of age: there are no data to recommend the use of Fluticasone Furoate Nasal Spray for the treatment of seasonal or perennial allergic rhinitis in children under 2 years of age. Fluticasone Furoate Inhalation Capsule: this should be administered as 1 inhalation once daily by the orally inhaled route. Fluticasone Furoate should be used at the same time every day. Do not use fluticasone furoate more than 1 time every 24 hours. Adults and adolescents aged 12 years and older: the starting dosage of Fluticasone Furoate should be based on the patient's asthma severity. The usual recommended starting dose for adults and adolescents aged 12 years and older who are not on an inhaled corticosteroid (ICS) is 100 mcg. For other adults and adolescents aged 12 years and older, the starting dose should be based on previous asthma drug therapy and disease severity. For adults and adolescents aged 12 years and older who do not respond to Fluticasone Furoate 100 mcg after 2 weeks of therapy, replacement with Fluticasone Furoate 200 mcg may provide additional asthma control. If a dosage regimen of Fluticasone Furoate fails to provide adequate control of asthma, the therapeutic regimen should be re-evaluated and additional therapeutic options should be considered, for example replacing the current strength of Fluticasone Furoate with a higher strength, initiating an ICS and long-acting beta 2-agonist (LABA) combination product, or initiating oral corticosteroids. The highest recommended daily dose in adults and adolescents aged 12 years and older is 200 mcg. After asthma stability has been achieved, it is desirable to titrate to the lowest effective dosage to help reduce the possibility of side effects. Pediatric patients aged 5 to 11 years: the recommended dosage for children aged 5 to 11 years is 50 mcg administered once daily.

Side Effects & Interactions

Side Effects

No side-effect data recorded yet.